Polymerase chain reaction in the staging of solid tumors

Eric G. Davis, Celia Chao, Kelly M. McMasters

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Polymerase chain reaction (PCR) is a molecular biology technique that holds great promise as a way to perform molecular staging of cancer by detecting very early metastatic disease. Significant data suggest that PCR analysis may play an important role in the management of colorectal cancer in the future. However, for PCR staging of breast cancer, progress awaits identification of gene markers that have sufficient sensitivity and specificity. Within the next few years, the results of the Sunbelt Melanoma Trial and other ongoing studies will determine whether PCR evaluation of sentinel lymph nodes and peripheral blood cells has prognostic relevance in melanoma. The future of cancer management will likely revolve around the molecular staging of tumors, and PCR is but one method that may better define subgroups of patients that are appropriate candidates for various anticancer therapies.

Original languageEnglish (US)
Pages (from-to)135-143
Number of pages9
JournalCancer Journal
Volume8
Issue number2
DOIs
StatePublished - Apr 1 2002
Externally publishedYes

Fingerprint

Neoplasm Staging
Polymerase Chain Reaction
Melanoma
Molecular Biology
Colorectal Neoplasms
Blood Cells
Breast Neoplasms
Sensitivity and Specificity
Genes
Neoplasms

Keywords

  • Breast cancer
  • Cancer
  • Colorectal cancer
  • Melanoma
  • Polymerase chain reaction
  • Solid tumors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Polymerase chain reaction in the staging of solid tumors. / Davis, Eric G.; Chao, Celia; McMasters, Kelly M.

In: Cancer Journal, Vol. 8, No. 2, 01.04.2002, p. 135-143.

Research output: Contribution to journalArticle

Davis, Eric G. ; Chao, Celia ; McMasters, Kelly M. / Polymerase chain reaction in the staging of solid tumors. In: Cancer Journal. 2002 ; Vol. 8, No. 2. pp. 135-143.
@article{71a7342227034730977c5d513492f8a4,
title = "Polymerase chain reaction in the staging of solid tumors",
abstract = "Polymerase chain reaction (PCR) is a molecular biology technique that holds great promise as a way to perform molecular staging of cancer by detecting very early metastatic disease. Significant data suggest that PCR analysis may play an important role in the management of colorectal cancer in the future. However, for PCR staging of breast cancer, progress awaits identification of gene markers that have sufficient sensitivity and specificity. Within the next few years, the results of the Sunbelt Melanoma Trial and other ongoing studies will determine whether PCR evaluation of sentinel lymph nodes and peripheral blood cells has prognostic relevance in melanoma. The future of cancer management will likely revolve around the molecular staging of tumors, and PCR is but one method that may better define subgroups of patients that are appropriate candidates for various anticancer therapies.",
keywords = "Breast cancer, Cancer, Colorectal cancer, Melanoma, Polymerase chain reaction, Solid tumors",
author = "Davis, {Eric G.} and Celia Chao and McMasters, {Kelly M.}",
year = "2002",
month = "4",
day = "1",
doi = "10.1097/00130404-200203000-00007",
language = "English (US)",
volume = "8",
pages = "135--143",
journal = "Cancer Journal from Scientific American",
issn = "1528-9117",
publisher = "Association Pour le Developpement de la Communication Cancerologique",
number = "2",

}

TY - JOUR

T1 - Polymerase chain reaction in the staging of solid tumors

AU - Davis, Eric G.

AU - Chao, Celia

AU - McMasters, Kelly M.

PY - 2002/4/1

Y1 - 2002/4/1

N2 - Polymerase chain reaction (PCR) is a molecular biology technique that holds great promise as a way to perform molecular staging of cancer by detecting very early metastatic disease. Significant data suggest that PCR analysis may play an important role in the management of colorectal cancer in the future. However, for PCR staging of breast cancer, progress awaits identification of gene markers that have sufficient sensitivity and specificity. Within the next few years, the results of the Sunbelt Melanoma Trial and other ongoing studies will determine whether PCR evaluation of sentinel lymph nodes and peripheral blood cells has prognostic relevance in melanoma. The future of cancer management will likely revolve around the molecular staging of tumors, and PCR is but one method that may better define subgroups of patients that are appropriate candidates for various anticancer therapies.

AB - Polymerase chain reaction (PCR) is a molecular biology technique that holds great promise as a way to perform molecular staging of cancer by detecting very early metastatic disease. Significant data suggest that PCR analysis may play an important role in the management of colorectal cancer in the future. However, for PCR staging of breast cancer, progress awaits identification of gene markers that have sufficient sensitivity and specificity. Within the next few years, the results of the Sunbelt Melanoma Trial and other ongoing studies will determine whether PCR evaluation of sentinel lymph nodes and peripheral blood cells has prognostic relevance in melanoma. The future of cancer management will likely revolve around the molecular staging of tumors, and PCR is but one method that may better define subgroups of patients that are appropriate candidates for various anticancer therapies.

KW - Breast cancer

KW - Cancer

KW - Colorectal cancer

KW - Melanoma

KW - Polymerase chain reaction

KW - Solid tumors

UR - http://www.scopus.com/inward/record.url?scp=0036517952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036517952&partnerID=8YFLogxK

U2 - 10.1097/00130404-200203000-00007

DO - 10.1097/00130404-200203000-00007

M3 - Article

C2 - 11999947

AN - SCOPUS:0036517952

VL - 8

SP - 135

EP - 143

JO - Cancer Journal from Scientific American

JF - Cancer Journal from Scientific American

SN - 1528-9117

IS - 2

ER -